Masserini et al. carried out a study in which they compared 46 obese OSAS patients with the control group including 37 healthy individuals, as a result of which it was determined that the serum adiponectin levels decrease independent of the BMI and insulin resistance [15]. This evidence concerns the gene ADIPOQ and Insulin resistance.